Significant reductions in MTB loads were observed in the lungs, liver, and spleen of mice treated with synergistic combinations of AMPs (e.g., HNP-1) and anti-TB drugs such as isoniazid and rifampicin [42,43]. The gene discussed is ADSL; the disease is tuberculosis.